Jyong Biotech

Jyong Biotech

Pharmaceuticals
Jyong Biotech Ltd is a science-driven biotechnology company based in Taiwan and is committed to developing and commercializing innovative and differentiated new drugs (plant-derived) mainly specializing in the treatment of urinary system diseases, with an initial focus on the markets of the U.S., the EU and Asia (primarily Taiwan and mainland China). It has been dedicated to the research and development of new drugs with high safety and efficacy. It has been developing a series of drug candidates, including one core drug candidate at NDA stage, one clinical-stage key drug candidate and other preclinical-stage drug candidates.

$180.9M

Market Cap • 9/22/2026

2018

(8 years)

Founded

2025

(1 year ago)

IPO

NASDAQ

Listing Exchange

Flag of Taiwan

Taiwan

Country

Valuation

P/B

P/S

P/EBITDA

P/OCF

P/FCF

P/E

BVPS

EPS

Market Cap

Market Cap

180,9M

EV

198,3M

EV/Revenue

0

EV/EBITDA

-79,1

EV/EBIT

-76,1

Payout

Dividend Per Share

0

Dividend Yield

0%

Buyback Yield

-9,8%

Total Yield

-9,8%

Payout

0%

Retained Earnings

-37,8M

Profitability

Gross Margin

EBITDA Margin

EBIT Margin

Net Margin

D&A/EBITDA

0%

R&D/Revenue

0%

Capex/Revenue

0%

Capex/D&A

0%

Capex/OCF

0%

SBC/OCF

% PPE

15,2%

% Goodwill

0%

ROE

15,2%

ROIC

Growth

CAGR Op. Income 5Y

1,3%

CAGR Net Income 5Y

19,5%

CAGR EPS 5Y

24,6%

CAGR OCF 5Y

22,8%

Leverage

N.D./EBITDA

Debt/Equity

0%

Current Ratio

0,4

Quick Ratio

0,4

Interest Coverage

Premium

Unlock 100% of the data and have immediate access on more than 6.000 companies with updated information!
  • Unrestricted access
  • Unlimited data history
  • Analysis videos
  • Quarterly highlights
  • Customizable financials table
  • Ranking
  • Discussions

...and much more!

Get Premium